Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for moderate to severe traumatic brain injury
PACTR202209548995270Recruiting
- Sponsor
- Faculty of Pharmacy, Damanhour University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of acetylcysteine in traumatic brain injury (TBI) (2 arms), sponsored by Faculty of Pharmacy, Damanhour University. Primary endpoint: Neuron-specific enolase level at day 7. Started Oct 2022; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on PACTR202209548995270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202209548995270.